Professional Documents
Culture Documents
FSHN 250 Statin Presentation
FSHN 250 Statin Presentation
LET'S TALK
STATINS
Gwendoline Balto
Esther Birkey
Iulia Ciubotariu
Sophia Cook
Presentation Overview
Introduction to the drug Excretion
Absorption Risks
Distribution Summary
Introduction
What is this drug?
3,5-dihydroxyglutaric acid moiety
Substituents on the ring define
solubility and properties=various
forms
Introduction
What does this drug do?
Blocks the active site of HMG-CoA
reductase which blocks the STATINS
conversion of HMG-CoA to
mevalonic acid = reduction in
hepatic cholesterol synthesis
Question
How do statins reduce cholesterol?
A.) Because cholesterol is an essential nutrient, statins only
remove small chunks of cholesterol particles from the
circulatory system
Cholesterol
becomes an First statin FDA approved
obvious risk discovered by
Akira Endo
Statin Medications
Water solibility
Affects Affects
Similarities
chemical structure
pharmacokinetic profile
lipid motility efficacy
Enterocyte
Bloodstream
Hepatocytes
Absorption
Gastrointestinal hemorrhage